Condition
Neonatal Morbidity
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07263490Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
NCT03991091Phase 4CompletedPrimary
Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor
NCT06941974Not ApplicableRecruiting
Partnering With Antenatal Navigators to Transform Health in Pregnancy
NCT06926946Not ApplicableNot Yet Recruiting
SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes
NCT00832143Not ApplicableCompletedPrimary
Effect of Referral Card on Neonatal Medical Care Seeking for Institutional Births in Urban Lucknow
Showing all 5 trials